SUPPRESSION OF FIBROSIS IN CHRONIC HEPATITIS C PATIENTS WITH CONTINUOUS ANTI-INFLAMMATORY DRUG THERAPY FOLLOWING INITIAL INTERFERON THERAPY
スポンサーリンク
概要
著者
-
YAMADA Gotaro
Department of Gastroenterology and Metabology, Kawasaki Hospital
-
Yamada Gotaro
Department Of Internal Medicine Center For Liver Disease Kawasaki Hospital Kawasaki Medical School
-
Yamada Gotaro
Center Of Liver Diseases Kawasaki Hospital Kawasaki Medical School
-
MAHMOOD Sabina
Department of Internal Medicine, Center for Liver Disease, Kawasaki Hospital, Kawasaki Medical Schoo
-
NIIYAMA Gouichi
Department of Internal Medicine, Center for Liver Disease, Kawasaki Hospital, Kawasaki Medical Schoo
-
Niiyama Gouichi
Department Of Internal Medicine Center For Liver Disease Kawasaki Hospital Kawasaki Medical School
-
Mahmood Sabina
Department Of Internal Medicine Center For Liver Disease Kawasaki Hospital Kawasaki Medical School
-
Mahmood Sabina
Department Of Clinical Research And Internal Medicine Center Of Liver Diseases Kawasaki Hospital Kaw
-
Niiyama Gouichi
Center Of Liver Diseases Kawasaki Hospital Kawasaki Medical School
-
YAMADA Gotaro
Department of Clinical Research, Center for Liver Disease, Kawasaki Hospital, Kawasaki Medical School
関連論文
- Guidelines for the antiviral therapy of hepatitis C virus carriers with normal serum aminotransferase based on platelet counts
- A Scanning Electron Microscopic Study of Subcapsular Lymphatic Capillaries of the Normal Liver and the Liver in Budd-Chiari Syndrome after Chemical Digestion
- Control of oxidative stress and reduction in biochemical markers by Vitamin E treatment in patients with nonalcoholic steatohepatitis : a pilot study
- Clinical significance of intrahepatic interleukin-8 in chronic hepatitis C patients
- Long term follow-up of a group of chronic hepatitis C patients treated with anti-inflammatory drugs following initial interferon therapy
- Laparoscopic Microwave Coagulation for the Treatment of Hepatocellular Carcinoma
- Photographic Monitoring under Intravenous Sedation
- SUPPRESSION OF FIBROSIS IN CHRONIC HEPATITIS C PATIENTS WITH CONTINUOUS ANTI-INFLAMMATORY DRUG THERAPY FOLLOWING INITIAL INTERFERON THERAPY
- Clinical usefulness of the branched DNA assay version 2 in predicting the efficacy of Interferon treatment in a group of chronic HCV patients based on serotype
- Quantitative analysis of wild-type and precore mutant hepatitis B virus in carriers
- A prospective study showing poor prognosis in Japanese NASH patients with fibrosis stage F3-4
- Long-term outcome and hepatocellular carcinoma development in chronic hepatitis B or cirrhosis patients after nucleoside analog treatment with entecavir or lamivudine
- Inhibition of hepatocellular carcinoma by PegIFNα-2a in patients with chronic hepatitis C : a nationwide multicenter cooperative study